BNP Paribas Financial Markets’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$760M Buy
825,867
+116,671
+16% +$118M 0.37% 42
2025
Q4
$762M Buy
709,196
+233,315
+49% +$223M 0.35% 44
2025
Q3
$363M Sell
475,881
-358,487
-43% -$267M 0.19% 84
2025
Q2
$650M Sell
834,368
-20,014
-2% -$15.6M 0.37% 37
2025
Q1
$706M Buy
854,382
+166,750
+24% +$139M 0.42% 37
2024
Q4
$531M Sell
687,632
-22,367
-3% -$18.5M 0.3% 56
2024
Q3
$629M Sell
709,999
-339
-0% -$305K 0.42% 37
2024
Q2
$643M Sell
710,338
-47,158
-6% -$37.7M 0.52% 25
2024
Q1
$589M Buy
757,496
+499,542
+194% +$356M 0.52% 26
2023
Q4
$150M Sell
257,954
-208,036
-45% -$121M 0.17% 133
2023
Q3
$250M Buy
465,990
+148,044
+47% +$76.3M 0.32% 48
2023
Q2
$149M Sell
317,946
-211,990
-40% -$88.9M 0.19% 107
2023
Q1
$182M Buy
529,936
+63,582
+14% +$21.4M 0.26% 83
2022
Q4
$171M Buy
466,354
+205,993
+79% +$73M 0.26% 76
2022
Q3
$84.2M Sell
260,361
-204,085
-44% -$64.7M 0.13% 148
2022
Q2
$151M Buy
464,446
+35,752
+8% +$10.7M 0.24% 91
2022
Q1
$123M Buy
428,694
+130,927
+44% +$33.7M 0.17% 124
2021
Q4
$82.2M Buy
297,767
+24,347
+9% +$6.17M 0.12% 184
2021
Q3
$63.2M Buy
273,420
+110,188
+68% +$27.2M 0.09% 243
2021
Q2
$37.5M Buy
163,232
+23,217
+17% +$4.66M 0.05% 402
2021
Q1
$26.2M Buy
140,015
+1,739
+1% +$340K 0.04% 458
2020
Q4
$23.3M Sell
138,276
-490,922
-78% -$73.3M 0.04% 423
2020
Q3
$93.1M Buy
629,198
+291,499
+86% +$45.1M 0.13% 145
2020
Q2
$55.4M Sell
337,699
-1,556,196
-82% -$239M 0.1% 188
2020
Q1
$263M Sell
1,893,895
-74,089
-4% -$10.2M 0.54% 25
2019
Q4
$259M Sell
1,967,984
-24,566
-1% -$2.85M 0.47% 29
2019
Q3
$223M Sell
1,992,550
-445,890
-18% -$49.6M 0.4% 45
2019
Q2
$270M Buy
2,438,440
+555,463
+29% +$65.4M 0.54% 25
2019
Q1
$244M Sell
1,882,977
-135,681
-7% -$16.5M 0.53% 25
2018
Q4
$234M Sell
2,018,658
-300,241
-13% -$33.5M 0.55% 21
2018
Q3
$249M Buy
2,318,899
+27,689
+1% +$2.77M 0.37% 41
2018
Q2
$196M Sell
2,291,210
-745,746
-25% -$61.3M 0.33% 52
2018
Q1
$235M Buy
3,036,956
+1,599,222
+111% +$129M 0.44% 34
2017
Q4
$121M Sell
1,437,734
-336,626
-19% -$28.6M 0.22% 91
2017
Q3
$152M Sell
1,774,360
-107,733
-6% -$8.84M 0.37% 50
2017
Q2
$155M Buy
1,882,093
+1,096,722
+140% +$89.5M 0.47% 42
2017
Q1
$66.1M Buy
785,371
+597,347
+318% +$47.8M 0.17% 122
2016
Q4
$13.8M Buy
188,024
+82,759
+79% +$6.16M 0.06% 261
2016
Q3
$8.45M Sell
105,265
-32,007
-23% -$2.56M 0.03% 327
2016
Q2
$10.8M Sell
137,272
-298,786
-69% -$22.5M 0.05% 271
2016
Q1
$31.4M Sell
436,058
-109,797
-20% -$8.31M 0.13% 123
2015
Q4
$46M Buy
545,855
+395,717
+264% +$32.8M 0.11% 152
2015
Q3
$12.6M Sell
150,138
-37,320
-20% -$3.15M 0.03% 364
2015
Q2
$15.7M Buy
187,458
+36,453
+24% +$2.78M 0.04% 238
2015
Q1
$11M Sell
151,005
-353,820
-70% -$25.2M 0.03% 378
2014
Q4
$34.8M Sell
504,825
-33,501
-6% -$2.26M 0.12% 136
2014
Q3
$34.9M Buy
538,326
+215,103
+67% +$13.6M 0.03% 222
2014
Q2
$20.1M Sell
323,223
-197,255
-38% -$11.8M 0.02% 252
2014
Q1
$30.8M Sell
520,478
-8,220
-2% -$459K 0.02% 218
2013
Q4
$27M Sell
528,698
-87,824
-14% -$4.4M 0.02% 244
2013
Q3
$31M Buy
616,522
+513,240
+497% +$26.9M 0.02% 249
2013
Q2
$5.07M Buy
+103,282
New +$5.62M ﹤0.01% 504

Other funds holding LLY

BNP Paribas Financial Markets's LLY Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Eli Lilly (LLY) stake by 16% in Q1 2026, buying an estimated $118M and bringing the position to 825,867 shares worth $760M. The position accounts for 0.37% of the portfolio, ranked #42.

BNP Paribas Financial Markets first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $762M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • BNP Paribas Financial Markets held 825,867 shares of Eli Lilly worth $760M as of Q1 2026.
  • BNP Paribas Financial Markets bought 116,671 Eli Lilly shares in Q1 2026, an estimated $118M.
  • Eli Lilly made up 0.37% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #42 holding.
  • BNP Paribas Financial Markets first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • BNP Paribas Financial Markets's Eli Lilly position peaked at $762M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.